Inactive Instrument

Press Releases Biostage Inc Nasdaq

Equities

US09074M1036

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

Harvard Apparatus Regenerative Technology : March 19, 2024 - Investor Presentation	Mar. 18	PU
Harvard Apparatus Regenerative Technology : Q4 - 2023 HBIO Quarterly Earnings Presentation	Mar. 07	PU
Harvard Apparatus Regenerative Technology : Northland Capital Markets Institutional Investor Conference 2023	23-09-18	PU
Harvard Apparatus Regenerative Technology : Q2 - 2023 HBIO Quarterly Earnings Presentation	23-08-08	PU
Biostage Activated Mayo Clinic as the First Site for Clinical Trial in Severe Esophageal Disease	23-07-19	AQ
Purcell & Lefkowitz LLP Is Investigating Biostage, Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors	23-06-15	PR
Biostage to Host Investor Call	23-06-13	PR
Biostage Initiated Study Start-up Activities for Clinical Trial in Severe Esophageal Disease	23-05-31	AQ
BIOSTAGE, INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	23-04-10	AQ
Biostage Appoints Ron Packard to Board of Directors	23-04-10	AQ
BIOSTAGE, INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Other Events, Financial Statements and Exhibits (form 8-K)	23-04-06	AQ
Biostage Announces $6 Million Financing to Advance Clinical Trial	23-04-06	AQ
BIOSTAGE, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	23-03-30	AQ
BIOSTAGE, INC. : Unregistered Sale of Equity Securities, Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	23-03-14	AQ
BIOSTAGE, INC. : Entry into a Material Definitive Agreement, Change in Directors or Principal Officers, Other Events, Financial Statements and Exhibits (form 8-K)	23-03-07	AQ
Biostage Announces Chairman and CEO Transition	23-03-01	PR
BIOSTAGE, INC. : Unregistered Sale of Equity Securities, Change in Directors or Principal Officers (form 8-K)	23-01-26	AQ
BIOSTAGE, INC. : Unregistered Sale of Equity Securities, Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	23-01-12	AQ
Biostage Amends CEO Employment Agreement	23-01-12	PR
Biostage Selects IQVIA to Manage its FDA-Approved Clinical Trial in Severe Esophageal Disease, including Cancer	22-12-29	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Biostage Inc Nasdaq

Equities

US09074M1036

Press Releases

Filters